Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Assets (2016 - 2025)

Historic Assets for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $509.8 million.

  • Organogenesis Holdings' Assets rose 1423.52% to $509.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $509.8 million, marking a year-over-year increase of 1423.52%. This contributed to the annual value of $497.9 million for FY2024, which is 823.02% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Assets stood at $509.8 million, which was up 1423.52% from $461.1 million recorded in Q2 2025.
  • Organogenesis Holdings' Assets' 5-year high stood at $509.8 million during Q3 2025, with a 5-year trough of $319.2 million in Q1 2021.
  • Its 5-year average for Assets is $441.6 million, with a median of $450.3 million in 2023.
  • As far as peak fluctuations go, Organogenesis Holdings' Assets skyrocketed by 6424.27% in 2021, and later plummeted by 353.42% in 2024.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Assets stood at $443.3 million in 2021, then increased by 1.38% to $449.4 million in 2022, then rose by 2.37% to $460.0 million in 2023, then rose by 8.23% to $497.9 million in 2024, then grew by 2.4% to $509.8 million in 2025.
  • Its last three reported values are $509.8 million in Q3 2025, $461.1 million for Q2 2025, and $467.4 million during Q1 2025.